EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. Cytokinetics, Incorporated Transaction History

EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:

$1.49M
portfolio value

EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -7.00% -2.32K shares 191K $48.45 30.84K
Q2 2022 share Decrease -7.90% -2.84K shares -23K $39.29 33.17K
Q1 2022 share Decrease -1.29% -471 shares -338K $36.81 36.01K
Q4 2021 share Increase 0.00% 36.48K shares 1.66M $45.6 36.48K